Johnson & Johnson Gets Tanked while Drug Maker Stocks Pop in the Healthcare Sector

Through the early part of trading on Wednesday, August 31, 2011, these stocks are very active in the Healthcare (NYSE:XLV) sector.

Popular: Investing in Gold: Is Gold Demand Growing or Shrinking?.

Shares of Johnson & Johnson (NYSE:JNJ) are among the most actively traded stocks in the market. Shares sold off hard after a report at 10:15AM that “Johnson & Johnson, Boston Scientific Corp. (NYSE:BSX) and other makers of surgical mesh may have to submit added safety data to regulators to keep their products on the market under a Food and Drug Administration staff recommendation,” according to Bloomberg. There are 2.4 million shares trading hands at $65.97(+20 cents), making up a dollar volume of $158.8 million.

Stock Price Performance: From August 2, 2011, to August 30, 2011, the stock price had risen $2.90 (4.6%) from $62.87 to $65.77. The stock price saw one of its best stretches over the last year between September 7, 2010 and September 20, 2010 when shares rose for 10 straight trading days, rising 5.8% (+$3.27). It saw one of its worst periods between July 22, 2011 and August 4, 2011 when shares fell for 10 straight trading days, falling 7.3% (-$4.84).

Shares of Pfizer Inc. (NYSE:PFE) are among the most actively traded stocks in the market. The drug maker continues to benefit from the approval of its new lung cancer drug Xalkori. They have a dollar volume today of $167.1 million, based on a current price of $19.07 (+19 cents) and 8.8 million shares being traded.

Stock Price Performance: From July 5, 2011, to August 30, 2011, the stock price had fallen $1.67 (-8.1%) from $20.55 to $18.88. The stock price saw one of its best stretches over the last year between April 21, 2011 and May 2, 2011 when shares rose for seven straight trading days, rising 6.2% (+$1.21). It saw one of its worst periods between July 6, 2011 and July 18, 2011 when shares fell for nine straight trading days, falling 5.5% (-$1.13).

Shares of Merck & Co Inc. (NYSE:MRK) are among the most actively traded stocks in the market. Yesterday the drug maker had more key claims dropped in their fourth case Fosamax alleging causes jaw damage. There are 2.5 million shares trading hands at $33.09(+39 cents), making up a dollar volume of $81.5 million.

Stock Price Performance: From July 5, 2011, to August 30, 2011, the stock price had fallen $2.79 (-7.9%) from $35.49 to $32.70. The stock price saw one of its best stretches over the last year between April 21, 2011 and May 4, 2011 when shares rose for nine straight trading days, rising 7.4% (+$2.49). It saw one of its worst periods between July 21, 2011 and August 4, 2011 when shares fell for 11 straight trading days, falling 12.9% (-$4.67).

Shares of Abbott Laboratories (NYSE:ABT) are among the most actively traded stocks in the market. The stock had EPS estimates lowered by a penny. They have a dollar volume today of $67.4 million, based on a current price of $51.98 (+19 cents) and 1.3 million shares being traded.

Stock Price Performance: From July 1, 2011, to August 29, 2011, the stock price had fallen $1.41 (-2.7%) from $52.62 to $51.21. The stock price saw one of its best stretches over the last year between March 25, 2011 and April 4, 2011 when shares rose for seven straight trading days, rising 4.6% (+$2.18). It saw one of its worst periods between July 22, 2011 and August 2, 2011 when shares fell for eight straight trading days, falling 5.2% (-$2.75).

Shares of Bristol-Myers Squibb Company (NYSE:BMY) have a dollar volume of $84.3 million based on a current price of $29.59(+47 cents) and 2.8 million shares traded. The company has been catching a bid since their joint venture with Pfizer — atrial fibrillation treatment, Eliquis — received solid data in the The New England Journal of Medicine.

Stock Price Performance: From June 6, 2011, to August 30, 2011, the stock price had risen $1.47 (5.3%) from $27.65 to $29.12. The stock price saw one of its best stretches over the last year between August 31, 2010 and September 13, 2010 when shares rose for nine straight trading days, rising 4.1% (+$1.03). It saw one of its worst periods between January 3, 2011 and January 11, 2011 when shares fell for seven straight trading days, falling 2.5% (-63 cents).